Allstocks.com's Bulletin Board Post A Reply
my profile login | register | search | faq | forum home

» Allstocks.com's Bulletin Board » Hot Stocks Free for All ! » Is anyone getting Peter_Leeds or Optimal_Gain? » Post A Reply

Post A Reply
Login Name:
Password:
Message Icon: Icon 1     Icon 2     Icon 3     Icon 4     Icon 5     Icon 6     Icon 7    
Icon 8     Icon 9     Icon 10     Icon 11     Icon 12     Icon 13     Icon 14    
Message:

HTML is not enabled.
UBB Code™ is enabled.

 

Instant Graemlins Instant UBB Code™
Smile   Frown   Embarrassed   Big Grin   Wink   Razz  
Cool   Roll Eyes   Mad   Eek!   Confused   BadOne  
Good Luck   More Crap   Wall Bang   Were Up   Were Down    
Insert URL Hyperlink - UBB Code™   Insert Email Address - UBB Code™
Bold - UBB Code™   Italics - UBB Code™
Quote - UBB Code™   Code Tag - UBB Code™
List Start - UBB Code™   List Item - UBB Code™
List End - UBB Code™   Image - UBB Code™

What is UBB Code™?
Options


Disable Graemlins in this post.


 


T O P I C     R E V I E W
ChrisNC  - posted
If so what are their picks this month.
 
Kenry  - posted
if u want their picks, buy their service
 
ChrisNC  - posted
quote:
Originally posted by Kenry:
if u want their picks, buy their service
Yeah I was wanting to see if my picks matched up tcow avca jlwt ibzt homz ctkh.pk IESV pdpr PGHI msitf and I am watching exgl Almost all of these are on their pivot point and waiting to break resistance. What do you think about these


 

realityinc21  - posted
quote:
Originally posted by ChrisNC:
If so what are their picks this month.

CHRIS,

I WILL POST UNDER PETER LEEDS PICKS THREAD HERE ON THIS BOARD ON TUES AND THRUS ABOUT 10 P.M. OR WHEN THEY COME OUT.

I DO NOT THINK THEY WILL LET ME CUT AND PASTE BUT IF I CAN I WILL POST THE PROFILE. IF NOT I WILL JUST POST THE PICKS.

I HAVE FOUND THAT THE PICKS GO UP ABOUT 25% BUT FALL VERY FAST. HAVE TO GET IN EARLY AND WATCH AND GET OUT. NOT A BAD DAY TRADE. I HAVE NOT BEEN REAL IMPRESSSED WITH HIS PICKS.

HOPE THIS WILL HELP AND SAVE PEOPLE SOME MONEY. GOOD LUCK TRADING AND THANKS FOR THE STOCK PICKS AND POSTS THAT YOU BRING TO THE TABLE.

------------------
DIANA
 

realityinc21  - posted
quote:
Originally posted by ChrisNC:
If so what are their picks this month.

THIS WAS THRUSDAYS PICK--


PMSI NASDAQ Prime Medical Services Inc
512.328.2892 PrimeMedical.com Shares Outstanding: 17,080,000

The following report and company descriptions are presented on this page as originally published and will not be updated. Therefore some time-sensitive data may no longer be accurate. Be sure to consult our Hot List to get our original opinions on buy and sell price ranges.

January 29, 2004.


Highlights

PMSI is the leading provider of lithotripsy in the U.S.

PMSI is affiliated with 24% of the urologists in the U.S. and performs
more than 18% of all lithotripsy procedures

PMSI is the only fully integrated specialty vehicle company in the U.S.

The company also has over 55% of the U.S. coach manufacturing market

PMSI recently signed a Definitive Merger agreement with their largest competitor




Outlook - Prime Medical Services Inc. (PMSI) is a stable, refocused, energized, diversified company operating in the lithotripsy and specialty vehicles market. While the company maintains leading positions in both business segments, they continue to have excellent long-term growth potential.

Men are afflicted with kidney stones more than twice as frequently as women, with the highest incidence occurring in men 45 to 64 years of age. The exact cause of kidney stone formation is unclear, and there is no known preventive cure in the vast majority of cases.

While there has always been a demand for mobile medical trailers, the events of September 11, have created an increased demand for mobile command & control centers and vehicles designed for law enforcement purposes.

A streamlined company, PMSI has in place a strong foundation for growth, one that has the potential to significantly impact the company’s bottom line and shareholder equity.

Business Profile - PMSI is an industry leader in providing healthcare services to the urology community, and is a market leader of specialty vehicles for use in the medical and broadcast & communication industries.

PMSI is the country’s leading provider of lithotripsy, a non-invasive therapy for kidney stone disease, typically performed on an outpatient basis. Lithotripsy remains an effective treatment alternative, costing about half that of invasive procedures.

Each year PMSI performs approximately 38,000 of these procedures, (which is more than 18% of the U.S lithotripsy market) through a network of approximately 360 hospitals and surgery centers in 34 states.

Through its wholly owned subsidiary AK Specialty Vehicles, PMSI is also a global leader in the design, engineering, and manufacturing of specialty vehicles for the transport of high technology medical, command & control, and broadcast & communication equipment.

This is an important segment as the specialty vehicle business has been explosive. Federal, state and municipal governments have a need to maintain a fleet of command and control vehicles for homeland security. Moreover, orders for specialty vehicles are expected to increase as those damaged or used in the Iraq war are replaced.

PMSI has an installed base of 1,800 specialty medical units; as the life of a unit is approximately 5 years, this should lead to a large recurring revenue stream of replacement units. In addition, PMSI has an installed base of about 1,700 broadcast units.

Fundamental Analysis - On November 11, PMSI announced its financial results for the third quarter ended September 30, 2003. Total revenue for the third quarter was $39.6 million, compared with $43.4 million for the same quarter a year ago. Net income for the period was $1.8 million, or $0.11 per share, compared with $3.2 million, or $0.19 per share, in the third quarter of 2002.

PMSI’s President & CEO, Brad A. Hummel, commented, "Operating results, while improved sequentially from last quarter's...continued to be affected by the weakness we have experienced in the medical imaging segment of our specialty vehicle manufacturing division. Lithotripsy operations improved sequentially, as procedure volume increased with seasonal demand and we made further progress in reducing operating costs."


"We reduced the outstanding balance under our senior credit line by $5.0 million during the quarter, from $18.0 million to $13.0 million. Subsequent to September 30, 2003, we paid down an additional $5.0 million, resulting in an outstanding balance of $8.0 million out of an available $50.0 million."
Mr. Hummel continued, "Following an intensive three-year effort, we are nearing the end of the lithotripsy re-engineering process. We renegotiated 240 hospital contracts, consolidated numerous partnerships and divested interest in three we did not manage."


"As a result of these efforts, the business is increasingly more stable. Steady pricing, more predictable procedure volume and minority interest expense add to our confidence that we can project our baseline economics and begin moving forward."
"We are evaluating several expansion partnerships and, as evidenced by today's announcement of our pending acquisition of Medstone International, we plan to broaden the products and services we can bring to the urology market."

Recent News - On November 11, PMSI and Medstone International, Inc. announced the execution of a definitive Merger Agreement pursuant to which PMSI will acquire Medstone for stock. Upon completion of the merger, Medstone will become a wholly owned subsidiary of PMSI.

Medstone, based in Aliso Viejo, California, is a leading manufacturer of lithotripsy systems and urology tables and a prominent provider of fee-per-procedure lithotripsy services. Medstone's was the first FDA approved device to treat both kidney stones and gallstones. With more than 130 lithotripters in operation worldwide, and more than 325 urology and patient handling tables in use, the Medstone devices are well established in the urology office and hospital market. For the year ended December 31, 2002, Medstone had revenues of $23 million.


CEO, Brad A. Hummel, stated, "This combination is an important step in broadening our urology platform and maintaining our prominence in the urology market. As we near completion of a three year process of re-engineering our lithotripsy operations, we see a Prime / Medstone combination as a catalyst for growth."
Mr. Hummel concluded, "Upon completion of the merger, we plan to rapidly integrate Medstone's service business into our existing operations in order to capitalize on strategic opportunities... The transaction is accretive to Prime's earnings, and adds considerable balance sheet benefits. Medstone has no long-term debt and net working capital of $16.5 million, including more than $7 million in cash as of September 30, 2003."

Conclusion - PMSI is a strong, energized, diversified company operating in the lithotripsy and specialty vehicles market. While the company maintains leading positions in both business segments, there is still plenty of room for additional growth.


Even though PMSI performs more than 18% of the lithotripsy procedures executed each year in the U.S., new contracts with hospitals and ambulatory surgery centers, coupled with additional physicians joining the joint ventures could help drive the company’s growth in this business.
Looking ahead, the Medstone acquisition, once completed, will be immediately accretive to earnings and substantially expand the landscape of PMSI’s urology business. Moreover, a significant R&D investment by Medstone over the past several years is culminating in the introduction of two new products which are slated to reach the market in early 2004.


The company’s manufacturing segment is also well positioned to capitalize on new opportunities, especially in light of the ongoing military activity in Iraq, and increase in federal grant monies to government agencies and municipalities for spending on homeland security.
As of their last fiscal report, PMSI’s Command & Control group had a backlog of $10.8 million, with an additional $2.4 million under letter of intent. The Homeland Security market remains brisk, and the Broadcast unit's backlog was $12.1 million.

A refocused company, PMSI has in place a strong foundation for excellent long-term growth, one that has the potential to significantly impact the company’s bottom line and shareholder equity.


--------------------------------------------------------------------------------


------------------
DIANA
 

ChrisNC  - posted
quote:
Originally posted by realityinc21:
THIS WAS THRUSDAYS PICK--


PMSI NASDAQ Prime Medical Services Inc
512.328.2892 PrimeMedical.com Shares Outstanding: 17,080,000

The following report and company descriptions are presented on this page as originally published and will not be updated. Therefore some time-sensitive data may no longer be accurate. Be sure to consult our Hot List to get our original opinions on buy and sell price ranges.

January 29, 2004.


Highlights

PMSI is the leading provider of lithotripsy in the U.S.

PMSI is affiliated with 24% of the urologists in the U.S. and performs
more than 18% of all lithotripsy procedures

PMSI is the only fully integrated specialty vehicle company in the U.S.

The company also has over 55% of the U.S. coach manufacturing market

PMSI recently signed a Definitive Merger agreement with their largest competitor




Outlook - Prime Medical Services Inc. (PMSI) is a stable, refocused, energized, diversified company operating in the lithotripsy and specialty vehicles market. While the company maintains leading positions in both business segments, they continue to have excellent long-term growth potential.

Men are afflicted with kidney stones more than twice as frequently as women, with the highest incidence occurring in men 45 to 64 years of age. The exact cause of kidney stone formation is unclear, and there is no known preventive cure in the vast majority of cases.

While there has always been a demand for mobile medical trailers, the events of September 11, have created an increased demand for mobile command & control centers and vehicles designed for law enforcement purposes.

A streamlined company, PMSI has in place a strong foundation for growth, one that has the potential to significantly impact the company’s bottom line and shareholder equity.

Business Profile - PMSI is an industry leader in providing healthcare services to the urology community, and is a market leader of specialty vehicles for use in the medical and broadcast & communication industries.

PMSI is the country’s leading provider of lithotripsy, a non-invasive therapy for kidney stone disease, typically performed on an outpatient basis. Lithotripsy remains an effective treatment alternative, costing about half that of invasive procedures.

Each year PMSI performs approximately 38,000 of these procedures, (which is more than 18% of the U.S lithotripsy market) through a network of approximately 360 hospitals and surgery centers in 34 states.

Through its wholly owned subsidiary AK Specialty Vehicles, PMSI is also a global leader in the design, engineering, and manufacturing of specialty vehicles for the transport of high technology medical, command & control, and broadcast & communication equipment.

This is an important segment as the specialty vehicle business has been explosive. Federal, state and municipal governments have a need to maintain a fleet of command and control vehicles for homeland security. Moreover, orders for specialty vehicles are expected to increase as those damaged or used in the Iraq war are replaced.

PMSI has an installed base of 1,800 specialty medical units; as the life of a unit is approximately 5 years, this should lead to a large recurring revenue stream of replacement units. In addition, PMSI has an installed base of about 1,700 broadcast units.

Fundamental Analysis - On November 11, PMSI announced its financial results for the third quarter ended September 30, 2003. Total revenue for the third quarter was $39.6 million, compared with $43.4 million for the same quarter a year ago. Net income for the period was $1.8 million, or $0.11 per share, compared with $3.2 million, or $0.19 per share, in the third quarter of 2002.

PMSI’s President & CEO, Brad A. Hummel, commented, "Operating results, while improved sequentially from last quarter's...continued to be affected by the weakness we have experienced in the medical imaging segment of our specialty vehicle manufacturing division. Lithotripsy operations improved sequentially, as procedure volume increased with seasonal demand and we made further progress in reducing operating costs."


"We reduced the outstanding balance under our senior credit line by $5.0 million during the quarter, from $18.0 million to $13.0 million. Subsequent to September 30, 2003, we paid down an additional $5.0 million, resulting in an outstanding balance of $8.0 million out of an available $50.0 million."
Mr. Hummel continued, "Following an intensive three-year effort, we are nearing the end of the lithotripsy re-engineering process. We renegotiated 240 hospital contracts, consolidated numerous partnerships and divested interest in three we did not manage."


"As a result of these efforts, the business is increasingly more stable. Steady pricing, more predictable procedure volume and minority interest expense add to our confidence that we can project our baseline economics and begin moving forward."
"We are evaluating several expansion partnerships and, as evidenced by today's announcement of our pending acquisition of Medstone International, we plan to broaden the products and services we can bring to the urology market."

Recent News - On November 11, PMSI and Medstone International, Inc. announced the execution of a definitive Merger Agreement pursuant to which PMSI will acquire Medstone for stock. Upon completion of the merger, Medstone will become a wholly owned subsidiary of PMSI.

Medstone, based in Aliso Viejo, California, is a leading manufacturer of lithotripsy systems and urology tables and a prominent provider of fee-per-procedure lithotripsy services. Medstone's was the first FDA approved device to treat both kidney stones and gallstones. With more than 130 lithotripters in operation worldwide, and more than 325 urology and patient handling tables in use, the Medstone devices are well established in the urology office and hospital market. For the year ended December 31, 2002, Medstone had revenues of $23 million.


CEO, Brad A. Hummel, stated, "This combination is an important step in broadening our urology platform and maintaining our prominence in the urology market. As we near completion of a three year process of re-engineering our lithotripsy operations, we see a Prime / Medstone combination as a catalyst for growth."
Mr. Hummel concluded, "Upon completion of the merger, we plan to rapidly integrate Medstone's service business into our existing operations in order to capitalize on strategic opportunities... The transaction is accretive to Prime's earnings, and adds considerable balance sheet benefits. Medstone has no long-term debt and net working capital of $16.5 million, including more than $7 million in cash as of September 30, 2003."

Conclusion - PMSI is a strong, energized, diversified company operating in the lithotripsy and specialty vehicles market. While the company maintains leading positions in both business segments, there is still plenty of room for additional growth.


Even though PMSI performs more than 18% of the lithotripsy procedures executed each year in the U.S., new contracts with hospitals and ambulatory surgery centers, coupled with additional physicians joining the joint ventures could help drive the company’s growth in this business.
Looking ahead, the Medstone acquisition, once completed, will be immediately accretive to earnings and substantially expand the landscape of PMSI’s urology business. Moreover, a significant R&D investment by Medstone over the past several years is culminating in the introduction of two new products which are slated to reach the market in early 2004.


The company’s manufacturing segment is also well positioned to capitalize on new opportunities, especially in light of the ongoing military activity in Iraq, and increase in federal grant monies to government agencies and municipalities for spending on homeland security.
As of their last fiscal report, PMSI’s Command & Control group had a backlog of $10.8 million, with an additional $2.4 million under letter of intent. The Homeland Security market remains brisk, and the Broadcast unit's backlog was $12.1 million.

A refocused company, PMSI has in place a strong foundation for excellent long-term growth, one that has the potential to significantly impact the company’s bottom line and shareholder equity.


Thank you reality21 I think some people have forgot about grouping our resources and making us all wiser. On the stocks I listed I just started and they seem well far as potential(technical trading)I sold my store and wanted to go for the risk of something new well thank you for your help you are offering hopefully we will talk in the future. I'm linked with Scottrade so If you need to info with another prespective just ask me. Chris20nc@hotmail.com

------------------
Chris
 

dirtyharry  - posted
Stockprowler’s pick this week...

CareDecision Corp. (OTC BB: CDED)

2660 Townsgate Rd., Suite 300

Westlake Village, CA. 91361
Phone: 805-446-1973
Corporate Web Site: http://www.caredecision.net

Shares Outstanding: 121.1 million
Public Float: 30 million (estimated)
Market Capitalization: $ 7.3 million
Closing Price Friday 1/30/04: 6 cents


I don’t have to tell Stockprowler followers that January was a very good month. Anyone who bought the January pick after our profile report had an opportunity to make a nice profit. PlanetLink Communications, Inc. (OTC BB: PLKC) climbed as high as 21.5 cents in the weeks after our report … 877% higher than the closing price on the Friday prior to our report!
And, although that is a difficult act to follow, we believe our pick for the month of February 2004, CareDecision Corp. (OTC BB: CDED) could be even bigger! With the demand for Wi-Fi Internet applications expected to grow 1000% over the next three years, CareDecision's PDA Wi-Fi products offer patent pending solutions for the lodging, satellite media, and medical/e-health markets that are truly innovative.

On January 13, 2004 CareDecision Corp. reported that it has begun the commercial deployment of its Wi-Fi ResidenceWare™ product, beginning with approximately 480 units at nine hotels in the Midwest. The company’s ResidenceWare™ is a proprietary, patent-pending Wi-Fi product for hotels and motels furnishing electronic connectivity solutions across multiple markets. ResidenceWare™ provides hotel and motel owner/operators with a value-added array of Wi-Fi electronic features that enhance the quality of the service offerings to their guests, and also represents a recurring source of cooperative revenue through local advertising fees, transaction fees, and rental Internet connections. Hotel guests can choose from a broad menu of information, local services, travel, business conveniences, food deliveries and more via proprietary Wi-Fi powered PDAs. The ResidenceWare™ PDAs are physically affixed within the guest rooms at client hotels. Each network yields a monthly volume of electronic transactions from local merchants, broadband Internet connection revenues, local advertising revenue bases and revenues from other convenience services.

Navin Patel, the owner of 18 hotels that recently placed orders for the ResidenceWare™, product commented, “Many of us in the hotel business believe that the only way to make an extra dollar is by cutting expenses. But, by introducing this unique product everything has changed. My hotels have over 1100 rooms and we estimate, as a direct result of ResidenceWare™, an annual transaction revenue stream of almost $550,000 across my 18 hotels. With CareDecision's Co-op Ad revenue-sharing program, each of my hotels should add profits, and I can still save an extra dollar or two by cutting expenses elsewhere.”

Robert Cox, Chairman of CareDecision Corp., commented, “Our ResidenceWare™ product has been enthusiastically received by hotels throughout the Midwest. As we secure this beachhead of business, we can shortly turn our attention to the southeastern states and to California. Our recently announced credit facility has been of immeasurable help in this regard. With a second credit facility in the works, we plan more revenue implementation announcements in the near future.” CareDecision’s marketing initiative has resulted in orders and contracts from leading hostelries, including Ramada, Super 8, TraveLodge and Wingate, worth an estimated $3.3 million annually from 2004-2006.

On December 30, 2003, CareDecision Corp. reported that it has executed a Merchant Banking Agreement with Armada Group USA, Inc. and is implementing the first of an anticipated three secured, non-dilutive credit facilities that could total more than $3 million. The agreement also calls for Armada to assume a leadership role on behalf of CareDecision as it enters the closure phase on its agenda of initiatives. These include a $2-$3 million credit facility for the Company's ResidenceWare products, as well as anticipated alliances with a large satellite media concern. The Company is using this initial credit facility for the financing of the existing backlog that recently grew to 26 hotel contracts representing the installation of ResidenceWare™ Wi-Fi units to more than 1,600 hotel guestrooms - and an additional 6,700 guestrooms if follow-on hotels are installed.

The company has selected Dell to furnish its Axim X5 Handheld and its PowerEdge Servers. Linksys, a division of Cisco Systems, Inc., has been chosen for its Wireless-G Broadband Router and its instant Wireless Network CF Card. Keith Berman, founder and CTO of CareDecision Corp. commented, “The product selections place us on the brink of initiating a flood of Wi-Fi ResidenceWare™ system installations to existing contracted hotels, and to additional hotels in the order pipeline. This large 4th quarter roll-out will quickly move CareDecision into this virtually untapped market and activate a steady stream of progressive revenues that will hopefully permit a sooner than expected fulfillment of our long anticipated positive earnings objective.” Mr. Berman concluded, “CareDecision has already been identified as the industry pioneer. We envision being eventually recognized as the dominant provider of Wi-Fi PDA based electronic services to the broad hotel/motel industry. Our market success with ResidenceWare™ is inexorably linked to the feature depth, ease of use and durability of the hardware and associated components.”

On January 21, 2004 CareDecision Corp. announced it has received several offers for the acquisition of, or rights to, its e-health technologies, software applications and other medically-related intellectual properties. The Company reports that the offers received for its three major medical IT properties, if taken at their highest values, would aggregate in excess of $6 million. CareDecision Chairman Robert Cox commented, “The current offers under review value our medical technology at approximately $.05 per share. These bids, which are unsolicited, are for assets that are not part of the Company's current core businesses. The assets that underlie our core businesses would remain totally intact. It is clear to us that our attributes have not gone unrecognized in the e-health sector…”

CareDecision Corp. is currently in due diligence discussions with Texas-based MDU Services, Inc. The acquisition of MDUS would add to CareDecision's asset and customer revenue bases, provide complimentary security services and coveted European venture partners. MDUS provides private smart buildings, switched fast Ethernet, Wi-Fi Hot Spots, and voice, data and TV services to multiple tenant business and residential building sites, hotels/motels, managed care facilities and universities.

The lodging business is highly competitive. When one hotel/motel chain adopts and implements a new innovation others are forced to quickly follow or face losing market share. CareDecision Corp. is the first to get to market with its proprietary and unique information technology/network. The recent trickle of orders for its ResidenceWare™ product may soon become a flood as competitors in the lodging industry realize they must have what the competition has. CareDecision Corp. projected revenues of $15 million for 2004 could prove to be conservative.

Stockprowler’s prediction for shares of CDED is 20 cents short term. Long term we could be talking dollars/share… not pennies. The odds are good that CDED will soon be showing up on the radar of the bigger industry movers and shakers making CDED a likely acquisition target. This could turn out be one of the big plays of 2004. Please remember that trading in shares of CDED could be very volatile due to the highly speculative nature of this stock and the small float relative to the OTC BB.

Stockprowler does not receive compensation from companies we profile or from third parties… we never have and never will. We use our own money when we buy stocks, and even though we usually take a position in a stock before we profile a company, our purchases are always relatively small so that the chance of having an effect on a stock’s price when we buy or sell is negligible. Please read our full disclaimer.

Also, contrary to a commonly held belief, Stockprowler does not have access to insider information, nor do we want to, because trading on insider information is illegal! All information contained in our reports is available in the public record… and any written or verbal communication with company CEOs/ IR people strictly adheres to this rule. Readers are urged to read the company SEC filings and do their own due diligence before investing in this or any other stock.

Good Trading… Stockprowler




 

realityinc21  - posted
[QUOTE]Originally posted by dirtyharry:
[B]Stockprowler’s pick this week...

CareDecision Corp. (OTC BB: CDED)

Dirty Harry,

Thanks for info. Wow. I sure do like it when we all work together and try to help each other out.

Good luck trading.

------------------
DIANA
 

ChrisNC  - posted
quote:
Originally posted by dirtyharry:
Stockprowler’s pick this week...

CareDecision Corp. (OTC BB: CDED)

2660 Townsgate Rd., Suite 300

Westlake Village, CA. 91361
Phone: 805-446-1973
Corporate Web Site: http://www.caredecision.net

Shares Outstanding: 121.1 million
Public Float: 30 million (estimated)
Market Capitalization: $ 7.3 million
Closing Price Friday 1/30/04: 6 cents


I don’t have to tell Stockprowler followers that January was a very good month. Anyone who bought the January pick after our profile report had an opportunity to make a nice profit. PlanetLink Communications, Inc. (OTC BB: PLKC) climbed as high as 21.5 cents in the weeks after our report … 877% higher than the closing price on the Friday prior to our report!
And, although that is a difficult act to follow, we believe our pick for the month of February 2004, CareDecision Corp. (OTC BB: CDED) could be even bigger! With the demand for Wi-Fi Internet applications expected to grow 1000% over the next three years, CareDecision's PDA Wi-Fi products offer patent pending solutions for the lodging, satellite media, and medical/e-health markets that are truly innovative.

On January 13, 2004 CareDecision Corp. reported that it has begun the commercial deployment of its Wi-Fi ResidenceWare™ product, beginning with approximately 480 units at nine hotels in the Midwest. The company’s ResidenceWare™ is a proprietary, patent-pending Wi-Fi product for hotels and motels furnishing electronic connectivity solutions across multiple markets. ResidenceWare™ provides hotel and motel owner/operators with a value-added array of Wi-Fi electronic features that enhance the quality of the service offerings to their guests, and also represents a recurring source of cooperative revenue through local advertising fees, transaction fees, and rental Internet connections. Hotel guests can choose from a broad menu of information, local services, travel, business conveniences, food deliveries and more via proprietary Wi-Fi powered PDAs. The ResidenceWare™ PDAs are physically affixed within the guest rooms at client hotels. Each network yields a monthly volume of electronic transactions from local merchants, broadband Internet connection revenues, local advertising revenue bases and revenues from other convenience services.

Navin Patel, the owner of 18 hotels that recently placed orders for the ResidenceWare™, product commented, “Many of us in the hotel business believe that the only way to make an extra dollar is by cutting expenses. But, by introducing this unique product everything has changed. My hotels have over 1100 rooms and we estimate, as a direct result of ResidenceWare™, an annual transaction revenue stream of almost $550,000 across my 18 hotels. With CareDecision's Co-op Ad revenue-sharing program, each of my hotels should add profits, and I can still save an extra dollar or two by cutting expenses elsewhere.”

Robert Cox, Chairman of CareDecision Corp., commented, “Our ResidenceWare™ product has been enthusiastically received by hotels throughout the Midwest. As we secure this beachhead of business, we can shortly turn our attention to the southeastern states and to California. Our recently announced credit facility has been of immeasurable help in this regard. With a second credit facility in the works, we plan more revenue implementation announcements in the near future.” CareDecision’s marketing initiative has resulted in orders and contracts from leading hostelries, including Ramada, Super 8, TraveLodge and Wingate, worth an estimated $3.3 million annually from 2004-2006.

On December 30, 2003, CareDecision Corp. reported that it has executed a Merchant Banking Agreement with Armada Group USA, Inc. and is implementing the first of an anticipated three secured, non-dilutive credit facilities that could total more than $3 million. The agreement also calls for Armada to assume a leadership role on behalf of CareDecision as it enters the closure phase on its agenda of initiatives. These include a $2-$3 million credit facility for the Company's ResidenceWare products, as well as anticipated alliances with a large satellite media concern. The Company is using this initial credit facility for the financing of the existing backlog that recently grew to 26 hotel contracts representing the installation of ResidenceWare™ Wi-Fi units to more than 1,600 hotel guestrooms - and an additional 6,700 guestrooms if follow-on hotels are installed.

The company has selected Dell to furnish its Axim X5 Handheld and its PowerEdge Servers. Linksys, a division of Cisco Systems, Inc., has been chosen for its Wireless-G Broadband Router and its instant Wireless Network CF Card. Keith Berman, founder and CTO of CareDecision Corp. commented, “The product selections place us on the brink of initiating a flood of Wi-Fi ResidenceWare™ system installations to existing contracted hotels, and to additional hotels in the order pipeline. This large 4th quarter roll-out will quickly move CareDecision into this virtually untapped market and activate a steady stream of progressive revenues that will hopefully permit a sooner than expected fulfillment of our long anticipated positive earnings objective.” Mr. Berman concluded, “CareDecision has already been identified as the industry pioneer. We envision being eventually recognized as the dominant provider of Wi-Fi PDA based electronic services to the broad hotel/motel industry. Our market success with ResidenceWare™ is inexorably linked to the feature depth, ease of use and durability of the hardware and associated components.”

On January 21, 2004 CareDecision Corp. announced it has received several offers for the acquisition of, or rights to, its e-health technologies, software applications and other medically-related intellectual properties. The Company reports that the offers received for its three major medical IT properties, if taken at their highest values, would aggregate in excess of $6 million. CareDecision Chairman Robert Cox commented, “The current offers under review value our medical technology at approximately $.05 per share. These bids, which are unsolicited, are for assets that are not part of the Company's current core businesses. The assets that underlie our core businesses would remain totally intact. It is clear to us that our attributes have not gone unrecognized in the e-health sector…”

CareDecision Corp. is currently in due diligence discussions with Texas-based MDU Services, Inc. The acquisition of MDUS would add to CareDecision's asset and customer revenue bases, provide complimentary security services and coveted European venture partners. MDUS provides private smart buildings, switched fast Ethernet, Wi-Fi Hot Spots, and voice, data and TV services to multiple tenant business and residential building sites, hotels/motels, managed care facilities and universities.

The lodging business is highly competitive. When one hotel/motel chain adopts and implements a new innovation others are forced to quickly follow or face losing market share. CareDecision Corp. is the first to get to market with its proprietary and unique information technology/network. The recent trickle of orders for its ResidenceWare™ product may soon become a flood as competitors in the lodging industry realize they must have what the competition has. CareDecision Corp. projected revenues of $15 million for 2004 could prove to be conservative.

Stockprowler’s prediction for shares of CDED is 20 cents short term. Long term we could be talking dollars/share… not pennies. The odds are good that CDED will soon be showing up on the radar of the bigger industry movers and shakers making CDED a likely acquisition target. This could turn out be one of the big plays of 2004. Please remember that trading in shares of CDED could be very volatile due to the highly speculative nature of this stock and the small float relative to the OTC BB.

Stockprowler does not receive compensation from companies we profile or from third parties… we never have and never will. We use our own money when we buy stocks, and even though we usually take a position in a stock before we profile a company, our purchases are always relatively small so that the chance of having an effect on a stock’s price when we buy or sell is negligible. Please read our full disclaimer.

Also, contrary to a commonly held belief, Stockprowler does not have access to insider information, nor do we want to, because trading on insider information is illegal! All information contained in our reports is available in the public record… and any written or verbal communication with company CEOs/ IR people strictly adheres to this rule. Readers are urged to read the company SEC filings and do their own due diligence before investing in this or any other stock.

Good Trading… Stockprowler




Yeah Harry thanks alot I hope you,realityinc21 and I can continue our exchanges and maybe pick up some more people along the way. It would be nice to have alot of the services picks to compare and observe. Anyway good luck and keep a watch on iesv I got in at .055 its at .08 right now but it is looking promising. Thanks for your contribution.

 



Contact Us | Allstocks.com Message Board Home

© 1997 - 2021 Allstocks.com. All rights reserved.

Powered by Infopop Corporation
UBB.classic™ 6.7.2

Share